InvestorsHub Logo
Followers 13
Posts 763
Boards Moderated 0
Alias Born 06/26/2014

Re: trading.jeff post# 48109

Wednesday, 07/07/2021 9:00:08 AM

Wednesday, July 07, 2021 9:00:08 AM

Post# of 48316
Yes, the “collaboration” in the past was mainly just Merck providing Keytruda to OncoSec for their small trial. It appears Merck will have more involvement in this trial, however my concern is the length of time it will take to enroll 400 participants.

Past trials with TAVO have taken several years for just 30 patients. Hopefully with Merck’s involvement and the fact that it’s multinational, it will speed up the process. It will also help that OncoSec has fast track designation for melanoma.

We’ll see….